LGR5-Targeted Antibody-Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-16-0114
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Antibody–Drug Conjugate Hits Elusive HER2 + Breast Tumors

Cancer Discovery
Oncology
2013English

Tumor Stroma–targeted Antibody-Drug Conjugate Triggers Localized Anticancer Drug Release

Journal of Clinical Investigation
Medicine
2018English

Preclinical Evaluation of a GFRA1 Targeted Antibody-Drug Conjugate in Breast Cancer

Oncotarget
Oncology
2018English

Antibody-Based Delivery of IL2 and Cytotoxics Eradicates Tumors in Immunocompetent Mice

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Targeted PDT Agent Eradicates TrkC Expressing Tumors via Photodynamic Therapy (PDT)

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2014English

Studies on Antibody-Anticancer Drug Conjugate

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1984English

Targeted Therapy and Personalized Medicine in Gastrointestinal Stromal Tumors: Drug Resistance, Mechanisms, and Treatment Strategies

OncoTargets and Therapy
OncologyPharmacology
2019English

Native Quantitative Determination of Antibody-Drug Conjugate Affinity and Stability

Biophysical Journal
Biophysics
2019English

An Antibody-Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity Against a Broad Range of Solid Tumors

Cancer Research
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy